Blood Transfusion - Lexba Biotech

Blood Transfusion

In the realm of healthcare, the pursuit of excellence is inexorably intertwined with the imperative of patient safety. The life-saving benefits of blood transfusions are undeniable. However, recent years have borne witness to a heightened scrutiny surrounding adverse outcomes following blood transfusion. While transfusion-transmitted infections, blood component safety, and quality have traditionally commanded attention, the spotlight has shifted to the often overlooked domain of transfusion process safety. Studies reveal a concerning truth: approximately 70% of these errors occur at the bedside. This highlights the urgent need for a robust transfusion safety system that specifically targets this most error-prone stage. In a landscape where the National Accreditation Board for Hospitals & Healthcare Providers (NABH) emphasizes the imperative of avoiding wrong blood transfusion, Haemovigil emerges as a timely intervention. Its introduction marks a pivotal step towards aligning transfusion safety practices with stringent regulatory standards, ensuring adherence to best practices in healthcare delivery. Haemovigil has come out to be a revolutionary system poised to drastically minimize the risk of bedside transfusion errors. This innovative solution leverages a combination of advanced mechanical and software-based algorithms to effectively eliminate the human factor as a potential source of error during the critical transfusion process. Haemovigil primarily targets the critical issue of patient misidentification, a leading cause of potentially life-threatening bedside errors. While significant strides have been made in mitigating transfusion-transmissible diseases, preventable bedside errors related to patient identification remain a significant threat. SHOT has identified nine critical steps in the transfusion process of which sample collection and patient identification are most crucial. Thus, Haemovigilance system is a cost effective and easy method that makes use of a combination of a hardware and software to ensure a final and repeat check of patient identification before blood transfusion without hampering the workflow. This system guarantees pre-transfusion patient identification by requiring a verification of the patient’s unique identifier to unlock the box and access the blood component.

This multi-layered systems offers significant benefits:

  1. Haemovigil encrypted wristbands: This gets attached to all the patients admitted in the hospital and it has encrypted barcode labels. You can peel off one label and attach it to the samples being sent to the blood bank.
  2. Haemovigil Software: the label barcode attached to the samples will then be scanned on the software and as the data is put in, the digital transportation box will be locked and the key would be the number in the wristband of the patient.
  3. Haemovigil Digital transporter: The Haemovigil digital transportation box offers multifaceted benefits. Notably, it prevents the opening of the lock if a blood component is erroneously presented to the wrong patient, thereby averting potentially catastrophic consequences. 

Additionally, it facilitates the audit of the specimen-collection process, facilitating the early detection and mitigation of wrong-blood-in-tube errors. The terrific part is that its user-centric design epitomizes simplicity and efficiency. The incorporation of a physical barrier accessible solely through the correct patient’s wristband code instills confidence among our blood bank personnel and transfusionists alike. This assurance stems from the knowledge that the final bedside check is executed with unwavering precision, mitigating the risk of inadvertent errors. This innovative system fosters a collaborative environment, providing confidence and peace of mind to all stakeholders involved in the blood transfusion process. Haemovigil can start the potential to revolutionize transfusion practices in India, ensuring optimal patient safety and improved healthcare outcomes.

References:

  1. References Br J Haematol, 2005 Oct;131(1):8-12., Reducing adverse events in blood transfusion, Stainsby D, Russell J et al.
  2. NCPS patient misidentification study: a summary of root cause analyses. VA NCPS Topics in Patient Safety. Washington, DC, United States Department of Veterans Affairs, June-July 2003.
  3. Vox Sang. 2003 Jul;85(1):40-7., An international study of the performance of sample collection from patients.
  4. Stainsby, D., Russell, P., et al. (2005). Risks of transfusion errors: a literature review. Transfusion Medicine, 15(2), 127-139.

SHARE:

Queries? Need more details?
Get in Touch with us